Quick on the heels of last week’s Washington Post article discussing the dangers of stem cell therapy, a U.S. federal judge ruled in favour of the Food and Drug Administration (FDA) in…

Dr. David Gamm is a pediatric ophthalmologist investigating how stem cells can be used as a potential treatment for retinitis pigmentosa (RP) and age-related macular degeneration (AMD). Dr. Gamm’s research is supported…

With so many exciting possibilities in stem cell and gene therapy on the horizon, how does Fighting Blindness Canada choose which projects to fund? The answer is simple: we fund the best,…

Dr. Mary Sunderland, Director of Research and Education at Fighting Blindness Canada, recently sat down with civil liberties advocate Danielle McLaughlin on the Kelly & Company Podcast to discuss the dangers of…

Recently, an article published by the Washington Post discussed the growing number of stem cell clinics in the United States offering “cures” for conditions like age-related macular degeneration, multiple sclerosis, and Parkinson’s…

In light of a recent article published by the Globe and Mail regarding the potential correlation between Avastin injections and increased glaucoma rates specifically in British Columbia, Fighting Blindness Canada is republishing…